The UK government is taking a fresh look at gambling. A white paper, expected in spring 2022, will […]
Ayvakyt receives a positive opinion from the CHMP for the treatment of adults with advanced systemic mastocytosis
Market authorisation for twice yearly schizophrenia treatment which offers patients much-needed medication continuity
Novartis’ Sandoz reportedly the target of $25B buyout bid from Carlyle and Blackstone fkansteiner Tue, 02/01/2022 – 11:09
Novartis, Amgen settle their dueling lawsuits over migraine drug Aimovig esagonowsky Tue, 02/01/2022 – 10:36
Biogen’s Aduhelm support campaign backfires as CMS receives many more comments in favor of restrictive coverage: analyst fkansteiner […]
AstraZeneca runs first kidney disease focused Farxiga TV ad, getting in the homes of 37M people with this […]
CMS’ Biogen decision could spell problems for Lilly, Roche Alzheimer’s drugs, half of surveyed neurologists say badams Tue, […]
A Phase 1 clinical trial has demonstrated the safety and efficacy of a novel immunotherapy drug in the […]
Patients who leave hospital after a stay for covid-19 are far more likely to need to be readmitted […]